Hyperfine, Inc.

HYPR

US44916K1060

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 28/06/2024 BST			5-day change	1st Jan Change
0.85 ^USD	-11.00%		+2.83%	-24.11%

06-25	Transcript : Hyperfine, Inc. - Shareholder/Analyst Call
05-28	Hyperfine, Inc. Continues Global Market Expansion by Entering into A Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop®? System to India	CI

Hyperfine, Inc. Provides Earning Guidance for the Year 2024

May 13, 2024 at 09:13 pm

Hyperfine, Inc. provided earning guidance for the year 2024. For the year, Management expects revenue to be $12 Million to $15 Million.

Latest news about Hyperfine, Inc.

Transcript : Hyperfine, Inc. - Shareholder/Analyst Call	06-25
Hyperfine, Inc. Continues Global Market Expansion by Entering into A Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop®? System to India	05-28	CI
Jefferies Downgrades Hyperfine to Hold From Buy, Price Target is $0.90	05-14	MT
Transcript : Hyperfine, Inc., Q1 2024 Earnings Call, May 13, 2024	05-13
Hyperfine, Inc. Provides Earning Guidance for the Year 2024	05-13	CI
Hyperfine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
Earnings Flash (HYPR) HYPERFINE Posts Q1 Revenue $3.3M, vs. Street Est of $3.1M	05-13	MT
Hyperfine, Inc. Provides Earnings Guidance for the Year 2024	05-13	CI
Hyperfine, Inc. to Expand Global Market Reach in European Markets	05-10	CI
Hyperfine, Inc. Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in Care PMR Study	04-17	CI
Wells Fargo Trims Hyperfine's Price Target to $1.60 From $2.10, Keeps Equalweight Rating	03-22	MT
B. Riley Trims Hyperfine's PT to $1.30 From $1.70 After 'Disappointing' Q4 2023 Sales, 2024 Guidance; Maintains Buy Rating	03-22	MT
Transcript : Hyperfine, Inc., Q4 2023 Earnings Call, Mar 21, 2024	03-21
Earnings Flash (HYPR) HYPERFINE Posts Q4 Revenue $2.7M	03-21	MT
Hyperfine, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-21	CI
Hyperfine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-21	CI
Hyperfine, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	03-21	CI
Hyperfine, Inc. and Athletic Heart Cardiac and Metabolic Testing, Llc Announce Collaboration to Bring Portable Brain Imaging Screening to Current and Former Professional Athletes	02-21	CI
Hyperfine, Inc. Launches AI-Powered Brain Imaging Software for Enhanced Image Quality and Ease of Use	01-09	CI
Jefferies Starts Hyperfine With Hold Rating	11-30	MT
Transcript : Hyperfine, Inc., Q3 2023 Earnings Call, Nov 09, 2023	11-09
Hyperfine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Earnings Flash (HYPR) HYPERFINE Reports Q3 Revenue $2.3M, vs. Street Est of $2.95M	11-09	MT
Hyperfine, Inc. Provides Earnings Guidance for the Full Year 2023	11-09	CI
Investors Look Ahead to FOMC Meeting, Earnings Reports as US Futures Trend Higher Monday	30/10/23	MT

Hyperfine, Inc. is a health technology company. The Company provides a Swoop Portable Magnetic Resonance Imaging System (Swoop system), which is a portable magnetic resonance imaging (MRI) system capable of providing neuroimaging at the point of care. Its Swoop system produces images at a lower magnetic field strength than conventional MRI scanners. The Swoop system is a portable, ultra-low-field (ULF) MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. MRI is used in various clinical settings for medical diagnosis, the staging of disease, and follow-up treatment. It has designed Swoop system to address an unmet need in point-of-care medical imaging through a combination of hardware and artificial intelligence (AI)-powered software services. The Companyâs system operates from a Wi-Fi-capable tablet and integrates with picture archiving and communication systems (PACS).

Sector

Advanced Medical Equipment & Technology

Calendar

27/07/2024 - Alzheimer Association International Conference - Jude-Patrick Nnamdi Okafor, MD

More about the company

Income Statement Evolution

More financial data

Ratings for Hyperfine, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.85 USD

Average target price

1.267 USD

Spread / Average Target

+49.02%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Imaging Systems

	1st Jan change	Capi.
HYPERFINE, INC.	-24.11%	61.21M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-19.93%	12.37B
SONOSCAPE MEDICAL CORP.	-16.32%	2.35B
IRAY TECHNOLOGY COMPANY LIMITED	-50.40%	2.26B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-27.69%	1.19B
CORETAG, INC.	-.--%	1.12B
NANO-X IMAGING LTD.	+15.23%	424M
DETECTION TECHNOLOGY OYJ	+41.61%	305M
DRTECH CORPORATION	-11.50%	202M
VIEWORKS CO., LTD.	+3.70%	187M

Medical Imaging Systems

Hyperfine, Inc.

Equities

HYPR

US44916K1060

Advanced Medical Equipment & Technology

Hyperfine, Inc. Provides Earning Guidance for the Year 2024

Latest news about Hyperfine, Inc.

Chart Hyperfine, Inc.

Company Profile

Income Statement Evolution

Ratings for Hyperfine, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Imaging Systems